Cisplatin nephrotoxicity may be sex related

Kidney International

Volumn 83, Issue 6, 2013, Pages 1201-

  Nematbakhsh, Mehdi ^a   Nasri, Hamid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; CILASTATIN; CISPLATIN; ERYTHROPOIETIN; ESTROGEN; LOSARTAN; MAGNESIUM;

CHRONIC KIDNEY DISEASE; LETTER; LOW DRUG DOSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; SEX DIFFERENCE;

EID: 84882263805     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.37     Document Type: Letter

References (16)

1. Humanes B, Lazaro A, Camano S et al. Cilastatin protects against cisplatininduced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int 2012; 82: 652-663.
2. Eshraghi-Jazi F, Nematbakhsh M, Nasri H et al. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: gender related differences in rat model. J Res Med Sci 2011; 16: 1389-1396.
3. Nematbakhsh M, Ashrafi F, Safari T et al. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats. J Nephrol 2012; 25: 410-417.
4. Ashrafi F, Haghshenas S, Nematbakhsh M et al. The role of magnesium supplementation in cisplatin-induced nephrotoxicity in a rat model: no nephroprotectant effect. Int J Prev Med 2012; 3: 637-643.
5. Ashrafi F, Nematbakhsh M, Safari T et al. A Combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats. Iran J Kidney Dis 2012; 6: 361-365.
6. Nematbakhsh M, Ashrafi F, Pezeshki Z et al. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: which one is the first observation as side effect of cisplatin-induced toxicity in animal model. J Nephropathol 2012; 1: 190-193.
7. Haghighi M, Nematbakhsh M, Talebi A et al. The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences. Ren Fail 2012; 34: 1046-1051.
8. Nematbakhsh M, Pezeshki Z, Eshraghi-Jazi F et al. Vitamin E, vitamin C, or losartan is not nephroprotectant against cisplatin-induced nephrotoxicity in presence of estrogen in ovariectomized rat model. Int J Nephrol 2012; 2012: 284896.
9. Pezeshki Z, Nematbakhsh M, Mazaheri S et al. Estrogen abolishes protective effect of erythropoietin against cisplatin-induced nephrotoxicity in ovariectomized rats. ISRN Oncol 2012; 2012: 890310.
10. Rafieian-Kopaei M, Nasri H, Nematbakhsh M et al. Erythropoietin ameliorates gentamycin-induced renal toxicity: a biochemical and histopathological study. J Nephropathol 2012; 1: 109-116.
11. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathol 2012; 1: 81-82.
12. Tavafi M. Inhibition of gentamicin-induced renal tubular cell necrosis. J Nephropathol 2012; 1: 83-86.
13. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathol 2012; 1: 123-125.
14. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol 2012; 1: 162-163.
15. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathol 2012; 1: 61-64.
16. Nematbakhsh M, Talebi A, Nasri H et al. Some evidence for sex-based differences in cisplatin-induced nephrotoxicity in rats. Clin Exp Med Lett 2012; 53: 29-32.